Dysglycemias in pregnancy: from diagnosis to treatment. Brazilian consensus statement
Authors:
- Carlos Antonio NegratoCNCarlos Antonio Negrato
- Renan M MontenegroRMRenan M Montenegro
- Rosiane MattarRMRosiane Mattar
- Lenita ZajdenvergLZLenita Zajdenverg
- Rossana Pv FranciscoRFRossana Pv Francisco
- Belmiro Gonçalves PereiraBPBelmiro Gonçalves Pereira
- Mauro SancovskiMSMauro Sancovski
- Maria Regina TorloniMTMaria Regina Torloni
- Sergio A DibSDSergio A Dib
- Celeste E ViggianoCVCeleste E Viggiano
- Airton GolbertAGAirton Golbert
- Elaine Cd MoisésEMElaine Cd Moisés
Open Access
- 24 April 2010
- journal article
- Published by Springer Nature in Diabetology & Metabolic Syndrome
- Vol. 2 (1) , 27
Abstract
There is an urgent need to find consensus on screening, diagnosing and treating all degrees of DYSGLYCEMIA that may occur during pregnancies in Brazil, considering that many cases of DYSGLYCEMIA in pregnant women are currently not diagnosed, leading to maternal and fetal complications. For this reason the Brazilian Diabetes Society (SBD) and the Brazilian Federation of Gynecology and Obstetrics Societies (FEBRASGO), got together to introduce this proposal. We present here a joint consensus regarding the standardization of clinical management for pregnant women with any degree of Dysglycemia, on the basis of current information, to improve medical assistance and to avoid related complications of Dysglycemia in pregnancy to the mother and the fetus. This consensus aims to standardize the diagnosis among general practitioners, endocrinologists and obstetricians allowing the dissemination of information in basic health units, public and private services, that are responsible for screening, diagnosing and treating disglycemic pregnant patients.Keywords
This publication has 45 references indexed in Scilit:
- Association between different levels of dysglycemia and metabolic syndrome in pregnancyDiabetology & Metabolic Syndrome, 2009
- Managing Preexisting Diabetes for PregnancyDiabetes Care, 2008
- Management of diabetes from preconception to the postnatal period: summary of NICE guidanceBMJ, 2008
- Mild gestational hyperglycaemia as a risk factor for metabolic syndrome in pregnancy and adverse perinatal outcomesDiabetes/Metabolism Research and Reviews, 2008
- Risk of congenital anomalies in pregnant users of statin drugsBritish Journal of Clinical Pharmacology, 2007
- Contraceptive Counseling of Diabetic Women of Reproductive AgeObstetrics & Gynecology, 2006
- Excretion of Metformin Into Breast Milk and the Effect on Nursing InfantsObstetrics & Gynecology, 2005
- Committee opinion #267: exercise during pregnancy and the postpartum periodObstetrics & Gynecology, 2002
- Prevalence of gestational diabetes mellitus – do the new WHO criteria make a difference?Diabetic Medicine, 2000
- Toxic effects of atenolol consumed during breast feedingThe Journal of Pediatrics, 1989